RESUMEN
BACKGROUND: Juvenile Idiopathic Arthritis is a chronic inflammatory disease that affects 1 in 1000 children worldwide. Our population in the United Arab Emirates is diverse. The objective of this study is to describe the subtype frequency, demographic features and treatments received and outcome of our patients. METHODS: Patients with the diagnosis of Juvenile Arthritis identified through the hospital electronic medical records system (EMR), which was implemented for all medical documentation in January 2011. All patients included are patients who presented to our center for treatment and follow up from 2011 to end of 2021. Retrospective case notes review of patients electronic medical records with the diagnosis of JIA was performed. RESULTS: One hundred thirty-eight patients in total. Oligoarticular subtype was the most represented with 75 patients (55%) followed by Rheumatoid factor negative polyarticular JIA with 32 patients (23%) then Enthesitis related arthritis (ERA) with 10 patients (7%) then psoriatic (6%) then systemic JIA (5%). Undifferentiated subtype of 2%. The most diagnostic delay is in enthesitis related arthritis subtype with a mean of 11.4 months (6-25) followed by undifferentiated JIA with a mean of 7.5 months (4-8.5). 131 (96%) out of 138 received steroid treatment. Only 6 patients did not receive steroids. Out of 138 patients, 101 (73%) were on synthetic disease modifying medication methotrexate. Sixty-eight patients out of the total 138 required biologic treatment (49%). In total 93 patients achieved clinical remission (67%). In remission on treatment 78 patients which is (56%) of the total number of patients with follow up ranging from 1 to 5 years and 84% of patients in remission. In remission off treatment 15 patients (11% of all patients and 16% of patients in remission). CONCLUSION: The most common subtype in our cohort of patients is oligoarticular JIA. Longest delay is for ERA subtype. All our patients with oligoarticular JIA received Intra articular steroid injection as first line treatment. 49% of our patients received biologic treatment similar to rate in Northern Europe. Our remission rate is 67% with 11% of patients are in remission off treatment. Access to care remains a priority to treat patients effectively.
Asunto(s)
Antirreumáticos , Artritis Juvenil , Productos Biológicos , Niño , Humanos , Artritis Juvenil/tratamiento farmacológico , Antirreumáticos/uso terapéutico , Emiratos Árabes Unidos , Estudios Retrospectivos , Diagnóstico Tardío , Resultado del Tratamiento , Productos Biológicos/uso terapéutico , DemografíaRESUMEN
Each year in the U.S. more than 130,000 children are hospitalized for psychiatric reasons. The decision to hospitalize a child is based on a complex set of factors. In this study, a 12-item checklist of criteria for hospitalization adapted by the authors was tested for its ability to predict hospitalization in a cohort of 389 children between the ages of two and 12 who were evaluated for either inpatient or outpatient treatment. Eighty-seven (22 percent) of the children were subsequently hospitalized. In 95 percent of the cases, the checklist was able to correctly predict whether the patient was hospitalized. A shorter checklist of six items was also able to predict the subsequent form of treatment in 95 percent of the cases. Although such checklists cannot take the place of informed clinical decisions, they can serve as a guide to decision making, especially for inexperienced mental health workers, and as a tool for utilization review when treatment decisions are questioned.
Asunto(s)
Hospitalización , Trastornos Mentales/diagnóstico , Determinación de la Personalidad , Escalas de Valoración Psiquiátrica/estadística & datos numéricos , Niño , Trastornos de la Conducta Infantil/diagnóstico , Trastornos de la Conducta Infantil/psicología , Trastornos de la Conducta Infantil/terapia , Centros Comunitarios de Salud Mental , Conducta Peligrosa , Femenino , Humanos , Masculino , Trastornos Mentales/psicología , Trastornos Mentales/terapia , Psicometría , Derivación y ConsultaRESUMEN
The NIMH Diagnostic Interview Schedule for Children, a highly structured interview covering a broad range of clinically relevant symptoms and behaviors, was administered to 242 disturbed children and their parents. Parent and child were interviewed separately and were assessed twice at a median interval of 9 days. Intraclass correlations between symptom scores derived from the interviews indicated that parents were generally more reliable than children in reporting child symptoms. However, test-retest reliabilities showed an opposite age pattern for parent and child. The reliability of the child's report increased with age and was lower for children aged 6-9 than those aged 10-13 and 14-18. Conversely, the reliability of the parent's report decreased with the age of the child and was slightly higher for children aged 6-9 than those aged 10-13 and 14-18. These findings were interpreted in terms of children's cognitive development and age-related shifts in parents' perceptions and awareness of their children's behavior.